Efficacy of Cerebrospinal Fluid Beta- d -Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review-Reference-Cited by-同舟云学术

Efficacy of Cerebrospinal Fluid Beta- d -Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review

Published:2020-03-25 Issue:4 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Davis Christian¹,Wheat L. Joseph²,Myint Thein³,Boulware David R.⁴,Bahr Nathan C.⁵

Affiliation:

1. University of Kansas School of Medicine, Kansas City, Kansas, USA

2. MiraVista Diagnostics, Indianapolis, Indiana, USA

3. Division of Infectious Diseases, Department of Medicine, University of Kentucky, Lexington, Kentucky, USA

4. Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA

5. Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, Kansas, USA

Abstract

Several case reports and cohort studies have examined the use of (1,3)-beta- d -glucan measurement with cerebrospinal fluid to diagnose fungal meningitis. This systematic review aims to characterize the evidence regarding cerebrospinal fluid (1,3)-beta- d -glucan measurement to detect fungal meningitis. We searched PubMed for (1,3)-beta- d -glucan and each of several distinct fungi, cerebrospinal fluid, and meningitis. Summary data including diagnostic performance (where applicable) were recorded.

Funder

HHS | NIH | National Institute of Neurological Disorders and Stroke

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02094-19

Reference39 articles.

1. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis

2. Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United States

3. Fungal Meningitis